In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

From fine-tuning open source models to building agentic frameworks on top of them, the open source world is ripe with projects that support AI development.

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the recently revealed feature ...

Through his Google fellowship, Stoica seeks to apply model merging to create a cutting-edge vision encoder. A vision encoder ...